baber/WOPTO huggingface dataset:
Patent NZ-216332-A (NZ)
Title: Solid contact material containing lanthanum, and oxidative conversion of hydrocarbons
Inventor: KOLTS J H
IPC: C07C2/84
Filed: 1986-05-28
Abstract: A solid composition of matter selected from the group consisting of:(a) a component comprising: (1) an oxide of lanthanum and a component comprising: (2) at least one material selected from the group consisting of halogen ions, compounds containing halogen ions, tin and compounds containing tin; and(b) a component comprising: (1) at least one material selected from the group consisting of Group IA metals and compounds containing said metals, a component comprising: (2) at least one metal selected from the group consisting of lanthanum and compounds containing lanthanum and, optionally, a component comprising: (3) at least one material selected from the group consisting of halogen ions, compounds containing halogen ions, tin and compounds containing tin,and a method for the oxidative conversion of organic compounds to other organic compounds, particularly in the presence of a free oxygen containing gas. When the method is carried out in the presence of a free oxygen containing gas, a contact material including a Group IA metal, tin and, optionally, chloride ions has also been found to be effective.
Patent NZ-216468-A (NZ)
Title: Substituted phenylacetic acid amide drivatives and pharmaceutical compositions
Inventor: BERMAN E F
IPC: C07F9/12
Filed: 1986-06-10
Abstract: Substituted phenylacetic acid amide compounds, and pharmaceutically-acceptable salts thereof, of the formula: <CHEM> wherein X is O or S; R1 is H, OH or CH3; R2 is straight chain alkenyl, branched chain or cyclic hydrocarbon having from about 7 to about 24 carbon atoms; R3 is OH, OSO3-, OPO3<-><-> or a short chain ester with from about 1 to about 6 carbon atoms.
Patent NZ-223971-A (NZ)
Title: Dried green fruit: infused in carbohydrate and buffering salt solution prior to drying
Inventor: PERERA CONRAD OSTWALD
IPC: A23B7/148
Filed: 1988-03-22
Abstract: A method of producing a dried fruit product in which certain physical, chemical and/or sensory features are stabilised, comprising the steps of; infusing pieces of the fruit with a low molecular weight carbohydrate to a predetermined extent;  and drying the infused fruit pieces to a predetermined extent. A method of producing a green dried product from green-fleshed fruit, the method involving the step of preventing degradation of chlorophyll pigments in the fruit during the drying process.
Patent NZ-233864-A (NZ)
Title: Sterilising containers using microwave energy
Inventor: KENICHI IIJIMA
IPC: B65B55/16
Filed: 1990-05-30
Abstract: An irradiator furnace is connected to a square waveguide for propagation of microwave and provided through a top wall with a slot. A conveyor bucket conveys sealed containers along the slot with lower portions of the sealed containers being inserted through the slot into the irradiator furnace. The irradiator furnace includes therein a rail which extends from the lowest level at an inlet of the irradiator furnace to the highest level at an outlet of the irradiator furnace so as to support the sealed containers. The hot air furnace is provided above the irradiator furnace. A narrow passage extending from the outlet of the irradiator furnace is directly followed by a thermostatic station utilizing an IR heater. So the sealed containers are sterilized. To feed the sealed containers to the conveyor bucket of the sterilizer, a sealed container feeding hopper comprising a conveyor belt, a screw and a feeding wheel is provided. A sensor is provided to detect whether individual turns of a screw groove are properly loaded with the sealed containers or not and auxiliary feeding guides operatively associated with the sensor to feed the sealed containers to the screw.
Patent NZ-235181-A (NZ)
Title: Rna with ribonuclease activity for mrna of ripening genes
Inventor: UIJTEWAAL BERNARDUS
IPC: A01H5/08
Filed: 1990-09-05
Abstract: Ribozyme genes or ribozyme gene fragments can be synthesised on the basis of the c-DNA of ripening genes. They are then introduced into plant cells where they are expressed, causing virtually complete inhibition of the ripening enzymes.
Patent NZ-248956-A (NZ)
Title: Androstane derivatives; preparation and pharmaceutical compositions
Inventor: TUBA ZOLTAN
IPC: C07J43/00
Filed: 1993-10-14
Abstract: There is disclosed novel, therapeutically active androstane derivatives having neuromuscular blocking effect, which are substituted by a quaternary ammonium group in 16-position; pharmaceutically composition containing them; process for producing them; and novel intermediates for the production.
Patent NZ-262079-A (NZ)
Title: Rechargeable cell with manganese dioxide with positive electrode and rechargeable zinc negative electrode
Inventor: TOMANTSCHGER KLAUS
IPC: H01M50/491
Filed: 1994-02-28
Abstract: This invention teaches rechargeable manganese dioxide cells having alkaline electrolytes, zinc negative electrodes and manganese dioxide positive electrodes. In keeping with the present invention, the positive electrode is essentially unconstrained-that is, no cage is used in the cell to confine the positive electrode. During discharge of a rechargeable alkaline cell, the positive electrode may be inclined to swell, and during the charge cycle it may be inclined to contract or reduce its dimensions. However, the positive electrode is dimensioned so as to substantially fill the entire space allotted for it within the cell, while allowing for a slight accommodation for height-wise or longitudinal expansion or growth in bobbin cells. The positive electrode may include additives such as carbon or graphite to increase its electrical conductivity; hydrophobic agents such as PTFE, polyethylene or polypropylene to enhance the hydrogen permeability of the positive electrode and thereby lead to increased hydrogen recombination rates; and similar hydrophobic agents as well as hydrophillic additives to serve as lubricants and to reduce tool wear during manufacturing processes. Also, the discharge capacity of the negative electrode may be established so as to be in the range of from about 60% to about 120% of the theoretical one electron discharge capacity of the positive MnO2 electrode.
Patent NZ-267279-A (NZ)
Title: Child resistant blister pill package: pill dispensed only after movement through necked gate in blister chamber
Inventor: HAMILTON PETER WORTHINGTON
IPC: B65D75/36
Filed: 1994-05-17
Abstract: A dual chamber-child-resistant blister package is provided. The blisters of the package include a storage chamber and a discharge chamber. In addition, the blister includes restraint means for preventing the medicament from moving from the storage chamber to the discharge chamber until a predetermined force is applied to the blister package. The medicament may not be dispensed directly from the storage chamber, since a nonrupturable layer is located adjacent the storage chamber of the blister. The nonrupturable layer includes an opening, or a mechanism such as a score line for forming and opening) through which the medicament can pass adjacent the discharge chamber. A rupturable layer is also provided to seal the medicament within the blister. Typically, the rupturable layer is located adjacent the nonrupturable layer to seal the opening in the nonrupturable layer. The blister package may also include indicia associated with the blisters to help insure compliance with complex therapeutic regimens. The blister package may also include fold lines to help reduce the overall size of the blister package; thereby making it easier to transport.
Patent NZ-267909-A (NZ)
Title: Enzymatic compositions; formulation for stabilising liquid enzymatic compositions which contain at least one polymer, a c2-6 polyhydric alcohol and water
Inventor: JAQUESS PERCY A
IPC: C11D3/386
Filed: 1994-06-06
Abstract: A stabilizing formulation capable of enhancing the storage and shelf-life of liquid enzymatic compositions as well as acting as a dispersant aid for industrial process waters. Such stabilizing formulation contains at least one polymer selected from a poly(cellulosic)ether, an acrylic polymer, and a polyamide, a C2-C6 polyhydric alcohol and water. The polymer and mixture are present in an amount effective to stabilize, preferably in a combined amount effective to synergistically stabilize, one or more enzymes contained in a liquid enzymatic composition. A stabilized liquid enzymatic composition which contains one or more components of the stabilizing formulation and an enzyme. Methods for using the stabilizing formulation and preparing stabilized liquid enzymatic compositions are also described.
Patent NZ-271971-A (NZ)
Title: Coating a polymer substrate with a hydrophilic film by subjecting the substrate to a plasma in the presence of a working gas consisting of an organic compound and hydrogen peroxide
Inventor: VON DER HAEGEN HARRO MUELLER
IPC: G02C7/04
Filed: 1994-07-28
Abstract: The invention describes a process for the surface modification of a polymer, which comprises treating a polymer with a working gas comprising hydrogen peroxide and an organic compound in plasma form.
Patent NZ-295351-A (NZ)
Title: Plant for continuously sterilising milk and cream with the fluid flowing from vacuum chamber to sterilising device via heat exchanger
Inventor: JENSEN JENS ANDERS
IPC: A23C3/037
Filed: 1995-11-14
Abstract: PCT No. PCT/DK95/00453 Sec. 371 Date May 19, 1997 Sec. 102(e) Date May 19, 1997 PCT Filed Nov. 14, 1995 PCT Pub. No. WO96/15677 PCT Pub. Date May 30, 1996A plant for continuously sterilizing fluids, such as milk and cream comprises a sterilizing device (2) in which the fluid is sterilized while steam is fed thereto, and a vacuum chamber (1) for removal of the water from the fluid and from which the fluid is extracted by means of a pump (8). The vacuum chamber (1) is accommodated before the sterilizing device (2) when seen in the flow direction of the fluid, said vacuum chamber (1) being connection to said sterilizing device (2) through a first heat exchanger (11) for heating the fluid before it enters said sterilizing device (2).
Patent NZ-299835-A (NZ)
Title: Actinomycete promoter for the expression of p-450 cytochromes
Inventor: SERIZAWA NOBUFUSA
IPC: C12N9/02
Filed: 1996-11-27
Abstract: A 1 kbp length of the 5'-noncoding region of the gene encoding cytochrome P-450sca-2 in the actinomycete Streptomyces carbophilus has transcription promoter activity which is substrate inducible. When the 1 kbp region is shortened, transcription activity becomes constitutive and the shortened promoters can be used advantageously in expression systems, especially those expressing P-450sca-2 in the presence of ML-236B to produce pravastatin sodium.
Patent NZ-300994-A (NZ)
Title: 5-(4-substituted-piperidinyl)-3-aryl-pentanoic acid derivatives, preparation and medicaments
Inventor: DEMBOFSKY BRUCE THOMAS
IPC: C07D409/12
Filed: 1996-02-08
Abstract: Compounds of formula (I), wherein Q<1>, Q<2>, Q<3> and Q<4> have any of the meanings given in the specification, their N-oxided, and their pharmaceutically acceptable salts are nonpeptide antagonists of SP and NKA, useful for the treatment of asthma, etc. Also disclosed are pharmaceutical compositions, processes for preparing the compounds of formula (I) and intermediates.
Patent NZ-321607-A (NZ)
Title: Use of beta-d-galactopyranosyl-d-xylose for evaluating intestinal lactase and preparatory processes
Inventor: REYES JUAN JOSE ARAGON
IPC: C07H3/04
Filed: 1996-11-08
Abstract: The compounds of O- beta -D-galactopyranosyl-D-xyloses, particularly 2-O- beta -D-galactopyranosyl-D-xylose, and 3-O- beta -D-galactopyranosyl-D-xylose for use in evaluating levels of intestinal lactase. There is also disclosed a process for producing O- beta -D-galactopyranosyl-D-xyloses, comprising: (a) reacting a D-xylose and a substrate of beta -D-galactopyranoside in the presence of an enzyme beta -galactosidase, in an aqueous medium buffered to a pH comprised between 5.0 and 9.0 and at temperature between 4 and 37 DEG C; (b) deactivating the beta -galactosidase by heating at 100 DEG C when reaching the maximum yield of formation of disaccharides detected through thin layer chromatography; and (c)  isolating the formed disaccharides through filtration in a packed column with a thinner selected between water and water/ alcohol.
Patent NZ-332292-A (NZ)
Title: Use of 2-phenyl-1,2 benzisoselenazol-3(2H)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease
Inventor: MARUYAMA IKUO
IPC: A61K31/41
Filed: 1997-04-07
Abstract: The use of 2-phenyl-1,2-benzisoselenazol-3(2H)-one for producing a pharmaceutical preparation for the prophylaxis and/or therapy of dementia, senile dementia or Alzheimer-type dementia.  The effect of the drug is based on the action of reducing neuron toxicity induced by beta-amyloid protein.
Patent NZ-334742-A (NZ)
Title: Free standing bag or pack having a gusseted base having side portions sealed to each other
Inventor: KRAMER ANDRE
IPC: B65D30/10
Filed: 1999-09-19
Abstract: A method of making a self-standing bag comprising: (a) Taking a longitudinal sheet of film having two parallel longitudinal edges and having a first major surface and a second major surface, (b) Reducing the width (edge to edge) of the longitudinal sheet by creating with five folds a longitudinally extending pleat in the sheet material, the five folds providing a pleat being deployable to resemble the letter "M", (viz. the "M" being provided by (i) a first base region fold, (ii) a first apex fold, (iii) a base fold, (iv) a second apex fold, and (v) a second base region fold, (c) (Optionally) longitudinally sealing together the facing surfaces of the first major surface at or adjacent the first and second apex folds of the pleat, (d) (Optionally) transverse sealing together at substantially bag width intervals, each of the facing surfaces of the first major surface from the apex folds or at least towards the base region folds of the pleat, (e) Forming the pleated sheet material into a tube by bringing together the first major surface of the film at or immediately adjacent the parallel longitudinal edges of the film, (f) Transverse sealing the first major surface of the film together transversely across the leading end of the tube to form what will be one closed side of the bag in its upright self standing condition, and (g) Transverse sealing the first major surface of the film of the tube together a bag width distance from the leading end of the tube, to form what will be the other closed side of the bag in its upright self standing condition, the transverse sealing including or being followed by, severing the tube a bag width from the leading end to form a discrete bag.
Patent NZ-335467-A (NZ)
Title: Bifold door or window transoms includes a rectangular box section
Inventor: O'SULLIVAN SEAN FRANCIS
IPC: E06B1/16
Filed: 1999-04-28
Abstract: A door or window transom provided in part by an extrusion having a hollow box section (1) to be positioned entirely inwardly of a building envelope.  The hollow box section (1) is rectangular in cross section with the major axis of the at least rectangular form adapted to lie vertically in use.  Adjacent to one face of the rectangular form, on one side that is proximate to a glazing or other panel, there are two spaced seal retention features (6).  Interposed between the two seal retention features is a part of the extrusion to extend inwardly of the glazing or other panels.  Extending exteriorly of the glazing or other panel is another hollow box section (7) that is integrally formed with the first hollow box section (1).
Patent NZ-503166-A (NZ)
Title: Green coloured infrared and ultraviolet radiation absorbing privacy glass having a total iron concentration of 0.9-2%wt
Inventor: KRUMWIEDE JOHN F
IPC: C03C4/08
Filed: 1998-11-19
Abstract: A green coloured, infrared and ultraviolet radiation absorbing glass composition comprises a base glass portion comprising: a) 66 to 75% by weight of SiO2; b) 10 to 20% by weight of Na2O; c) 5 to 15% by weight of CaO; d) 0 to 5% by weight of MgO; e) 0 to 5% by weight of Al2O3 and f) 0 to 5% by weight of K2O and a solar radiation absorbing and colourant portion consisting essentially of g) 0.90 to 2.0% by weight of total iron; h) 0.17 to 0.52% by weight of FeO; i) 40 to 150 PPM of CoO; j) 250 to 800 PPM of Cr2O3; k) 0.1 to 1% by weight of TiO2; l) optionally 0.1 to 0.32% by weight of V2O5; m) optionally 0 to 0.5% by weight of MnO2; n) optionally 0 to 0.5% by weight of Nd2O3; o) optionally 0 to 2% by weight of SnO2; p) optionally 0 to 0.5% by weight of ZnO; q) optionally 0 to 0.015% by weight of MoO3 r) optionally 0 to 2% by weight of CeO2 and s) optionally 0 to 0.1% by weight of NiO.  The glass has a luminous transmittance (LTA) of up to 60% at a thickness of 0.160 inches. An automotive or a flat sheet glass can be formed from the above composition.
Patent NZ-504189-A (NZ)
Title: Use of beta recombinase in eukaryotic cells other than human cells for development of transgenic animals
Inventor: DIAZ VICENTE
IPC: C12N15/87
Filed: 1998-09-22
Abstract: Described is the use of prokaryotic beta recombinase in eukaryotic   cells,  especially  for  transgenic   work   in eukaryotic cells, excluding non-human cells, and the use  of prokaryotic     beta    recombinase    for     site-specific intramolecular  recombination  between  two  six  sites   in eukaryotic  cells.   The use of the  gene  coding  for  beta recombinase  for  promoting the deletion  of  DNA  sequences located  between  directly oriented six sites  in  mammalian cells  and  for catalysing site-specific resolution  of  DNA sequences in an extrachromosomal target introduced  into  an eukaryotic cell are also disclosed.
Patent NZ-509699-A (NZ)
Title: Antiviral macrocyclic compounds containing a cyclic amine moiety
Inventor: SKERLJ RENATO TONY
IPC: A61P31/12
Filed: 1999-07-08
Abstract: A macrocyclic compound or the acid addition salts and metal complexes thereof has the formula (V): V'-CR1R2-Ar2 or of formula (1a) V"-CR1R2-Ar1-CR3R4-N(R5)-(CR6R7)x-R8 wherein: V' is a cyclic polyamine moiety having a total of 9 to 24 members and from 3 to 6 optionally substituted amine nitrogens spaced by two or more optionally substituted carbon atoms from each together and which may optionally comprise a fused aromatic or heteroaromatic ring; V" is a cyclic polyamine moiety having a total of 9 to 24 members and 2 optionally substituted amine nitrogens spaced by two or more optionally substituted carbon atoms from each together and which may optionally comprise a fused aromatic or heteroaromatic ring;R1 to R7 are independently hydrogen, alkyl or cycloalkyl; Ar1 is an optionally substituted aromatic or heterocyclic group; Ar2 is an optionally substituted aromatic or heterocyclic group or is 4- phenylpiperazinyl or purin-1-ylmethyl; R8 is a heterocyclic group, an optionally substituted aromatic or heteroaromatic group or is mercaptan and x is 1 or 2. The compounds are useful in treating conditions mediated by the CXCR4 or CCR5 receptors.
Patent NZ-510561-A (NZ)
Title: Heterocycles that are NO-synthetase (NOS) inhibitors and their use in treating neurodegenerative conditions
Inventor: REHWINKEL HARTMUT
IPC: C07D221/22
Filed: 1999-09-20
Abstract: Described are compounds of formula (I), their tautomeric and isomeric forms and salts, a method for producing them and their use in medicaments. In which the substituents have the following meaning: R1 and R2 mean independently of one another a) hydrogen, b) C1-6 alkyl, c) OR7, d) NR7R8, e) CN, f) acyl, g) CO2R9, h) CONR7R8, i) SNR7R8, R3 means: a saturated or unsaturated C1-5 alkylene radical, which can be substituted in one to four places with OR7, NR11R12 or C1-4 alkyl in which one or two CH2 groups can be replaced by O, S(O)n, NR8, =N- or carbonyl, and which can be bridged with a methano, ethano or propano group R4 means: C1-4 alkyl, substituted with NR14R15 or R4 and R5 taken together with two adjacent atoms form a five- or six- membered carbocyclic compound, which can be substituted with NR14R15, R5 and R6 mean, independently of one another a) hydrogen, b) halogen c) OR7, d) C1-4 alkyl e) CF3, f) OCF3, R7, R18 and R19 mean, independently of one another a) hydrogen, b) C1-6 alkyl c) C6-10 aryl, which is optionally substituted with halogen or C1-4 alky,.d) COR10, CO2 R10, e) CONR18R19, R8, R11 and R12 mean, independently of one another: a) hydrogen, b) C1-6 alkyl, c) C6-10 aryl, which is optionally substituted with halogen or C1-4 alkyl, d) COR10, e) CO2R10, f) CONR18R19, g) CSNR18R19, R9, R10 and R20 mean, independently of one another: a) C1-6 alkyl, b) C6-10 aryl, which is optionally substituted with halogen or C1-4 alkyl, R14 and R15 mean, independently of one another: a) hydrogen, b) CO2R20, c) C1-6 alkyl, which is optionally substituted with halogen, hydroxy, C1-4 alkoxy, nitro, amino, C1-6 alkyl, trifluoromethyl, carboxyl, cyano, carboxyamido, C3-7 cycloalkyl, indanyl, 1,2,3,4- tetrahydronaphthyl, C6-10 aryl, five- or six-membered heteroaryl with one to four nitrogen, oxygen or sulphur atoms, which can be annulated with benzene, whereby the aryl radical and the heteroaryl radical can be substituted with halogen, hydroxy, C1-4 alkoxy, C1-4 alkyl, CF3, NO2, NH2, N(C1-4 alkyl)2 or carboxyl, or R14 and R15 together with the nitrogen atom from a five- to seven- membered saturated heterocycle, which can contain another oxygen, nitrogen or sulphur atom and can be substituted with C1-4alkyl or a phenyl, benzyl or benzoyl radical that is optionally substituted with halogen or an unsaturated five-membered heterocycle, which can contain one to three nitrogen atoms and can be substituted with phenyl, C1-4 alkyl, halogen or CH2-OH, and n means 0, 1 or 2.
Patent NZ-511124-A (NZ)
Title: Control system and method for an automatic door or gate
Inventor: LEIVENZON JACK
IPC: E05F15/14
Filed: 2000-05-19
Abstract: A control system for a door or gate which is movable between an open position and a closed position by an automated operator, comprising: (a) a door travel organiser which divides the door travel into a plurality of segments and each segment into a plurality of sectors; (b) a sensor to sense, at each sector, the resistance of the door or gate against opening and closing whilst moving between the open position and the closed position over a predetermined number of open-close cycles, and to generate at least one signal representative of that resistance in each segment over the open-close cycles; (c) a recorder connected to the sensor to receive each representative signal and to store such a signal; (d) a comparator to compare each signal with a resistance trip point set for each segment and generate a resistance profile for the door or gate over an open-close cycle of the door or gate; (e) a calculator to calculate the resistance trip point for the door or gate for each segment based upon the highest resistance encountered in any sector of that segment; and (f) a controller to receive each trip point and set each trip point as a threshold for each segment such that if resistance of the door or gate sensed by the sensor in any sector exceeds that threshold for that interval, the movement of the door or gate is interrupted.
Patent NZ-512942-A (NZ)
Title: Polynucleotides encoding the IL-13 binding chains of the interleukin receptor, pharmaceutical compositions comprising the protein and methods of identifying inhibitors
Inventor: COLLINS MARY
IPC: C12N5/10
Filed: 1999-12-13
Abstract: An IL-13 antagonist is used in the manufacture of a medicament for treating atopy. The antagonist is an IL-13bc protein, a soluble form of IL-13Ra1, an antibody to IL-13bc, IL-13bc binding fragment thereof , an antibody to IL-Ra1, an IL-13Ra1-binding fragment thereof , an antibody to IL-13 or an IL-13 binding fragment thereof. Preferably the IL-13bc protein comprises the amino acid sequence of SEQ ID NO:2 or 4.